MarketCap
Facebook
X
Telegram
Cardiovascular Systems Total Non Current Liabilities | CSII
Annual Total Non Current Liabilities Cardiovascular Systems
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 28.3 M | 31.4 M | 34.6 M | 6.01 M | 2 M | 117 K | 7.65 M | 13.1 M | 9.94 M | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 34.6 M | 117 K | 14.8 M |
Quarterly Total Non Current Liabilities Cardiovascular Systems
| 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 112 K | 123 K | 5.9 M | 123 K | 9.09 M | 10.6 M | 11.8 M | 10.6 M | 14.3 M | 15.8 M | 9.86 M | 15.8 M | 9.86 M | 9.94 M | 9.94 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 15.8 M | 112 K | 8.93 M |
Total Non Current Liabilities of other stocks in the Medical devices industry
| Issuer | Total Non Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Cutera
CUTR
|
430 M | - | -10.19 % | $ 1.99 M |  USA |
 |
EDAP TMS S.A.
EDAP
|
7.44 M | - | - | $ 162 M |  France |
 |
GenMark Diagnostics, Inc.
GNMK
|
85.2 M | - | - | $ 1.77 B | USA |
 |
Avinger
AVGR
|
12.7 M | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
24.8 M | - | - | $ 3.31 B | USA |
 |
Eargo
EAR
|
161 M | - | - | $ 10.2 M | USA |
 |
LENSAR
LNSR
|
3.44 M | $ 5.6 | -2.78 % | $ 67 M | USA |
 |
Allied Healthcare Products
AHPI
|
115 K | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
906 K | - | -5.86 % | $ 30.6 M | USA |
 |
Apollo Endosurgery
APEN
|
59 M | - | - | $ 475 M | USA |
 |
Aziyo Biologics
AZYO
|
35.2 M | - | 1.37 % | $ 20.5 M | USA |
 |
BioSig Technologies
BSGM
|
103 K | - | 37.08 % | $ 85.7 M | USA |
 |
BIOLASE
BIOL
|
5.69 M | - | -13.19 % | $ 166 K | USA |
 |
Outset Medical
OM
|
436 M | $ 4.04 | -4.49 % | $ 61.5 K | USA |
 |
AxoGen
AXGN
|
1.61 M | $ 39.49 | -0.6 % | $ 1.82 B | USA |
 |
Conformis
CFMS
|
29.2 M | - | - | $ 16.4 M | USA |
 |
Insulet Corporation
PODD
|
1.06 B | $ 163.26 | 3.08 % | $ 11.5 B | USA |
 |
Quanterix Corporation
QTRX
|
21.5 M | $ 3.67 | -6.38 % | $ 156 M | USA |
 |
CryoLife, Inc.
CRY
|
400 M | - | -4.14 % | $ 702 M | USA |
 |
Bruker Corporation
BRKR
|
1.28 B | $ 60.45 | -2.74 % | $ 9.18 B | USA |
 |
Sintx Technologies
SINT
|
1.76 M | $ 1.42 | -6.58 % | $ 3.94 M | USA |
 |
Soliton, Inc.
SOLY
|
4.28 K | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
568 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
3.08 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
39.9 M | - | - | $ 462 M | USA |
 |
TELA Bio
TELA
|
30.2 M | $ 0.69 | -2.81 % | $ 32.4 M | USA |
 |
Neovasc
NVCN
|
9.02 M | - | - | $ 111 M |  Canada |
 |
Dynatronics Corporation
DYNT
|
10 M | - | 14.99 % | $ 929 K | USA |
 |
Tactile Systems Technology
TCMD
|
14.1 M | $ 27.48 | 0.15 % | $ 629 M | USA |
 |
TransMedics Group
TMDX
|
34.5 M | $ 72.26 | 1.59 % | $ 2.46 B | USA |
 |
IRIDEX Corporation
IRIX
|
2.33 M | $ 0.89 | -3.38 % | $ 15.1 M | USA |
 |
Tandem Diabetes Care
TNDM
|
31.7 M | $ 17.12 | 1.3 % | $ 1.16 B | USA |
 |
Intersect ENT, Inc.
XENT
|
116 M | - | - | $ 955 M | USA |
 |
Second Sight Medical Products
EYES
|
2.36 M | - | -0.97 % | $ 54.4 M | USA |
 |
ClearPoint Neuro
CLPT
|
23.9 M | $ 14.12 | -2.55 % | $ 400 M | USA |
 |
Viemed Healthcare
VMD
|
14.6 M | $ 11.77 | 0.86 % | $ 458 M | USA |
 |
Avanos Medical
AVNS
|
322 M | $ 24.99 | 0.04 % | $ 1.16 B | USA |
 |
Beyond Air
XAIR
|
4.47 M | $ 5.16 | -5.67 % | $ 42.8 B | USA |
 |
Invacare Corporation
IVC
|
325 M | - | - | $ 24.7 M | USA |
 |
Xtant Medical Holdings
XTNT
|
16.8 M | $ 0.43 | -0.39 % | $ 60 M | USA |
 |
Cytosorbents Corporation
CTSO
|
14 M | $ 0.36 | -0.39 % | $ 22.4 M | USA |
 |
NanoVibronix
NAOV
|
18 | - | - | $ 1.08 M | USA |
 |
NuVasive
NUVA
|
763 M | - | - | $ 2.07 B | USA |
 |
Natus Medical Incorporated
NTUS
|
43.5 M | - | 1.94 % | $ 1.05 B | USA |
 |
Nevro Corp.
NVRO
|
183 M | - | - | $ 217 M | USA |
 |
Inogen
INGN
|
52.5 M | $ 6.15 | -2.69 % | $ 164 M | USA |